Mirion Technologies (NYSE:MIR) Shares Up 5.6% – Here’s What Happened

Mirion Technologies, Inc. (NYSE:MIR) rose 5.6% during trading on Wednesday . The company traded as high as $15.54 and last traded at $15.56. Approximately 1,647,094 shares were traded during trading, a decline of 24% from the average daily volume of 2,153,865 shares. The stock had previously closed at $14.74.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. The Goldman Sachs Group lifted their price objective on Mirion Technologies from $16.00 to $21.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Robert W. Baird initiated coverage on shares of Mirion Technologies in a report on Thursday, December 19th. They set an “outperform” rating and a $22.00 price objective on the stock. Citigroup boosted their target price on shares of Mirion Technologies from $18.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, December 4th. Finally, Baird R W upgraded shares of Mirion Technologies to a “strong-buy” rating in a research report on Thursday, December 19th. Three research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $19.25.

Mirion Technologies Stock Up 5.2 %

The firm’s 50 day moving average price is $17.10 and its 200-day moving average price is $13.71. The company has a current ratio of 2.16, a quick ratio of 1.55 and a debt-to-equity ratio of 0.43. The company has a market cap of $3.60 billion, a P/E ratio of -45.62 and a beta of 0.75.

Mirion Technologies (NYSE:MIR) last issued its earnings results on Tuesday, October 29th. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.02). Mirion Technologies had a negative net margin of 7.84% and a positive return on equity of 4.33%. The business had revenue of $206.80 million for the quarter, compared to the consensus estimate of $203.67 million. During the same quarter in the previous year, the firm posted $0.03 EPS. The business’s revenue was up 8.2% on a year-over-year basis. As a group, equities research analysts expect that Mirion Technologies, Inc. will post 0.33 EPS for the current year.

Insider Buying and Selling at Mirion Technologies

In other Mirion Technologies news, insider Emmanuelle Lee sold 3,405 shares of the business’s stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $14.27, for a total value of $48,589.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On Mirion Technologies

Institutional investors and hedge funds have recently modified their holdings of the business. Quest Partners LLC lifted its stake in Mirion Technologies by 680.5% in the third quarter. Quest Partners LLC now owns 6,728 shares of the company’s stock valued at $74,000 after buying an additional 5,866 shares in the last quarter. SkyView Investment Advisors LLC bought a new stake in Mirion Technologies in the 3rd quarter valued at $111,000. Integrated Advisors Network LLC acquired a new position in Mirion Technologies in the 3rd quarter worth $120,000. Paloma Partners Management Co bought a new position in Mirion Technologies during the 3rd quarter worth about $122,000. Finally, KBC Group NV raised its stake in shares of Mirion Technologies by 39.2% in the 4th quarter. KBC Group NV now owns 8,002 shares of the company’s stock valued at $140,000 after purchasing an additional 2,254 shares during the period. 78.51% of the stock is currently owned by institutional investors and hedge funds.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.